Rare Disease Biospecimens
Rare Disease Biospecimens
Advance breakthrough research in rare and hard to access
conditions with high-quality, deeply annotated biospecimens
collected through Sanguine’s nationwide direct-to-donor network
Unlock Access to Rare Donor Populations
Rare disease research often moves slowly not because of scientific limitations, but because donor access is limited and fragmented. Sanguine bridges this gap by connecting researchers directly with individuals living with rare and harder to access conditions. Our direct-to-donor model removes geographic and logistical barriers, enabling rapid, compliant, and donor-centric sample collection from some of the most difficult-to-reach populations.
Whether your work focuses on genetic disorders, immune dysregulation, metabolic diseases, or understudied inflammatory conditions, we provide reliable access to donor biospecimens and rich clinical data that help accelerate translational discovery
Why Partner with Sanguine for Rare Disease Biospecimen Solutions
A direct-to-donor model built for rare populations
Our nationwide donor community and in-home collection capabilities allow us to engage individuals anywhere in the U.S., including those with mobility limitations or low community prevalence.
Custom cohort recruitment for ultra-specific criteria
We recruit and screen donors to meet your exact inclusion/exclusion requirements, from genotypeconfirmed cohorts to treatmentnaïve or therapy-experienced donors.
Longitudinal and hard-to-collect samples
Track disease activity, therapeutic response, or biomarker dynamics over time through serial collections, even in very small populations.
Matched collections
Collect multiple biospecimen types from the same donor such as blood, PBMCs, plasma, serum, and urine, supporting integrative analyses.
Donor reported insights
For many rare conditions, donor-reported outcomes, flare patterns, and quality-of-life metrics are essential data streams. We integrate this information to complement your biospecimens with meaningful real-world context.
Deep clinical and molecular annotation
Receive comprehensive datasets that may include diagnosis details, treatment history, symptom onset, family history, genetic confirmation, imaging data, and more transforming biospecimens
into robust translational tools.
Ethical, compliant, and secure
All collections follow IRB-approved protocols, HIPAA-compliant de-identification standards, and stringent data-privacy frameworks (ISO 9001, ISO 27001, ISO 27701).
Neuro Disease Specimen Portfolio
Available biospecimen types
Whole blood, plasma, serum
PBMCs and leukopaks for immune and cellular research
Urine, saliva, and other non-blood biospecimens
Longitudinal and recall-on-demand collections
Comprehensive data annotation may include:
Demographics, diagnosis, and genetic confirmation (if available)
Disease onset, progression history, symptom patterns
Medication and treatment exposure
Family history and comorbid conditions
Donor-reported outcomes and disease activity scores
Biomarker, genomic, or metabolic data (when available)
Ethical Sourcing and Regulatory Compliance
- IRB-approved consent and study materials
- HIPAA-compliant de-identification and secure data handling
- ISO-certified quality, information security, and privacy systems
- Transparent communication and ongoing
engagement with donor communities
Empowering Rare Disease Research Across the R&D Spectrum
Mechanistic research
Study disease biology, genetic changes, inflammatory pathways, or metabolic derangements unique to rare conditions.
Biomarker discovery & validation
Use matched and longitudinal specimens to discover early predictors or progression markers.
Diagnostics development
Develop and validate diagnostic assays, including genetic, protein, and metabolic tests for early detection or subtype identification.
Therapeutic development
Support target validation, drug screening, preclinical work, and translational studies with well- characterized donor samples.
Cell & gene therapy research
Access high-quality PBMCs, leukopaks, or genetically defined donor cohorts to advance gene editing, cell therapy, and precision approaches
Clinical validation & post-market research
Leverage retrospective or prospective cohorts to support regulatory submissions, clinical validation, or real-world evidence studies
Ready to Advance Rare Disease Research?
Whether you’re building a targeted cohort for a specific mutation, seeking access to hard-to-find donor populations, or exploring biomarker development in rare condition, Sanguine provides the donor access and data depth your research requires.
Connect with our team to discuss your biospecimen needs or explore what’s available in our rare disease portfolio.